Screener
Kairos Pharma KAPA Q2 2025 Annual earnings
Reported August 12, 2025 · Before market open
EPS-$0.08Miss by $0.02
EPS estimate-$0.06
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.09
Versus estimates
Diluted EPS
FAQ
- When did Kairos Pharma report Q2 2025 earnings?
- Kairos Pharma (KAPA) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Kairos Pharma's Q2 2025 revenue and EPS?
- Kairos Pharma reported eps of $-0.08 for Q2 2025.
- Did Kairos Pharma beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.06 by $0.02.
- How did Kairos Pharma's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 306.1% from $-0.02.
- Where can I find Kairos Pharma's Q2 2025 SEC filings?
- You can read the 10-K/A periodic report (0001641172-25-021134) directly on SEC EDGAR. The filing index links above go to sec.gov.
